ClearPoint Neuro, Inc.

NasdaqCM:CLPT 株式レポート

時価総額：US$147.8m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

ClearPoint Neuro マネジメント

マネジメント 基準チェック /34

ClearPoint Neuro'sの CEO はJoe Burnettで、 Nov2017年に任命され、 の在任期間は 6.58年です。 の年間総報酬は$ 2.00Mで、 25.9%給与と74.1%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.91%を直接所有しており、その価値は$ 1.34M 。経営陣と取締役会の平均在任期間はそれぞれ3.3年と5.7年です。

主要情報

Joe Burnett

最高経営責任者

US$2.0m

報酬総額

CEO給与比率25.9%
CEO在任期間6.6yrs
CEOの所有権0.9%
経営陣の平均在職期間3.3yrs
取締役会の平均在任期間5.7yrs

経営陣の近況

Recent updates

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 09
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

ClearPoint Neuro: Macro-Induced Multiple Compression

Apr 25

Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?

Apr 19
Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?

Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Mar 15
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?

Jan 04
Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?

Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Dec 06
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?

Nov 06
Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

Aug 18
Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump

Apr 17
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump

Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Jan 03
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

ClearPoint Neuro: Continuous Great Execution

Sep 19

ClearPoint Neuro: Picks & Shovels Galore

Aug 19

ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

Aug 18
ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

ClearPoint Neuro:  A 'Picks And Shovels' Biotech Company

Jul 25

ClearPoint Neuro: Continuous Execution Despite Covid Headwind

May 20

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

Apr 25
Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides

Mar 18

ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

Jan 19
ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

ClearPoint Neuro: Underlying Growth Potential Concealed By COVID

Jan 14

ClearPoint Neuro: Becoming The Neurosurgical Platform Of Choice

Oct 01

ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company

Aug 06

Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?

Jul 19
Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?

Clearpoint Neuro (CLPT) Investor Presentation - Slideshow

May 28

Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation

May 27
Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation

US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results

May 13
US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results

CEO報酬分析

ClearPoint Neuro の収益と比較して、Joe Burnett の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$21m

Dec 31 2023US$2mUS$518k

-US$22m

Sep 30 2023n/an/a

-US$22m

Jun 30 2023n/an/a

-US$21m

Mar 31 2023n/an/a

-US$18m

Dec 31 2022US$2mUS$494k

-US$16m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$16m

Mar 31 2022n/an/a

-US$16m

Dec 31 2021US$1mUS$445k

-US$14m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$9m

Mar 31 2021n/an/a

-US$7m

Dec 31 2020US$784kUS$435k

-US$7m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$6m

Mar 31 2020n/an/a

-US$6m

Dec 31 2019US$864kUS$366k

-US$6m

Sep 30 2019n/an/a

-US$5m

Jun 30 2019n/an/a

-US$5m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018US$515kUS$360k

-US$6m

Sep 30 2018n/an/a

-US$7m

Jun 30 2018n/an/a

-US$7m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$930kUS$55k

-US$7m

報酬と市場: Joeの 総報酬 ($USD 2.00M ) は、 US市場 ($USD 680.27K ) の同規模の企業の平均を上回っています。

報酬と収益: Joeの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Joe Burnett (47 yo)

6.6yrs

在職期間

US$1,995,337

報酬

Mr. Joseph Michael Burnett, also known as Joe, has been Chief Executive Officer, President and Director of ClearPoint Neuro, Inc. since November 7, 2017. Mr. Burnett has spent his entire career in medical...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Joseph Burnett
President6.6yrsUS$2.00m0.91%
$ 1.3m
Danilo D'Alessandro
Chief Financial Officer3.4yrsUS$930.98k0.18%
$ 262.9k
Jeremy Stigall
Chief Business Officer1.4yrsUS$838.49kデータなし
Mazin Sabra
Chief Operating Officer1.7yrsデータなし0.16%
$ 236.6k
Ellisa Cholapranee
General Counsel & Secretary3.2yrsデータなしデータなし
Jacqueline Keller
Vice President of Marketing4.6yrsデータなしデータなし

3.3yrs

平均在職期間

41.5yo

平均年齢

経験豊富な経営陣: CLPTの経営陣は 経験豊富 であると考えられます ( 3.3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Joseph Burnett
President6.6yrsUS$2.00m0.91%
$ 1.3m
R. Fletcher
Independent Chairman of the Board7.1yrsUS$227.62k0.34%
$ 495.6k
B. Johnson
Independent Director4.8yrsUS$189.99k0.14%
$ 202.7k
Lynnette Fallon
Independent Director2.9yrsUS$202.49k0.11%
$ 161.7k
Pascal E. Girin
Independent Director9.8yrsUS$192.65k0.26%
$ 389.1k
Linda Liau
Independent Director2.6yrsUS$182.49k0.11%
$ 163.2k
Timothy Richards
Independent Director10.3yrsUS$194.75k0.22%
$ 331.8k
Matthew Klein
Director4.2yrsUS$174.99k0.11%
$ 158.6k

5.7yrs

平均在職期間

64yo

平均年齢

経験豊富なボード: CLPTの 取締役会 は 経験豊富 であると考えられます ( 5.7年の平均在任期間)。